Novel and established intestinal cell line models - An indispensable tool in food science and nutrition

Trends in Food Science and Technology

Volumn 22, Issue SUPPL. 1, 2011, Pages

  Langerholc, Tomaz ^a   Maragkoudakis, Petros A ^b   Wollgast, Jan ^b   Gradisnik, Lidija ^a   Cencic, Avrelija ^a  

^a UNIVERSITY OF MARIBOR   (Slovenia)

^b JOINT RESEARCH CENTRE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CELL LINES; FOOD COMPONENTS; FOOD SCIENCE; FUNCTIONAL CELLS; IN-VITRO; INDISPENSABLE TOOLS; INTESTINAL CELLS; PROBIOTICS;

ADSORPTION; BIOCHEMISTRY; CELL CULTURE;

CELLS;

SUIDAE;

EID: 80053385554     PISSN: 09242244     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tifs.2011.03.010     Document Type: Review

References (99)

1. Arulampalam V., Greicius G., Pettersson S. The long and winding road to gut homeostasis. Current Opinion in Gastroenterology 2006, 22:349-353.
2. Azenha M.A., Evangelista R., Martel F., Vasconcelos M.T. Estimation of the human intestinal permeability of butyltin species using the Caco-2 cell line model. Food and Chemical Toxicology 2004, 42:1431-1442.
3. Backhed F., Ley R.E., Sonnenburg J.L., Peterson D.A., Gordon J.I. Host-bacterial mutualism in the human intestine. Science 2005, 307:1915-1920.
4. Beaulieu J.F. Extracellular matrix components and integrins in relationship to human intestinal epithelial cell differentiation. Progress in Histochemistry and Cytochemistry 1997, 31:1-78.
5. Beiseigel J.M., Hunt J.R., Glahn R.P., Welch R.M., Menkir A., Maziya-Dixon B.B. Iron bioavailability from maize and beans: a comparison of human measurements with Caco-2 cell and algorithm predictions. The American Journal of Clinical Nutrition 2007, 86:388-396.
6. Bernasconi E., Fritsche R., Corthesy B. Specific effects of denaturation, hydrolysis and exposure to Lactococcus lactis on bovine beta-lactoglobulin transepithelial transport, antigenicity and allergenicity. Clinical & Experimental Allergy 2006, 36:803-814.
7. Berschneider H.M. Abstract of the annual meeting of the American gastroenterological association 1989.
8. Biasi F., Mascia C., Astegiano M., Chiarpotto E., Nano M., Vizio B., et al. Pro-oxidant and proapoptotic effects of cholesterol oxidation products on human colonic epithelial cells: a potential mechanism of inflammatory bowel disease progression. Free Radical Biology & Medicine 2009, 47:1731-1741.
9. Bodinier M., Legoux M.A., Pineau F., Triballeau S., Segain J.P., Brossard C., et al. Intestinal translocation capabilities of wheat allergens using the Caco-2 cell line. Journal of Agricultural and Food Chemistry 2007, 55:4576-4583.
10. Borst P., Elferink R.O. Mammalian ABC transporters in health and disease. Annual Review of Biochemistry 2002, 71:537-592.
11. Brunet J.L., Maresca M., Fantini J., Belzunces L.P. Human intestinal absorption of imidacloprid with Caco-2 cells as enterocyte model. Toxicology and Applied Pharmacology 2004, 194:1-9.
12. Candela M., Perna F., Carnevali P., Vitali B., Ciati R., Gionchetti P., et al. Interaction of probiotic Lactobacillus and Bifidobacterium strains with human intestinal epithelial cells: adhesion properties, competition against enteropathogens and modulation of IL-8 production. International Journal of Food Microbiology 2008, 125:286-292.
13. Cencic A., Langerholc T. Functional cell models of the gut and their applications in food microbiology-a review. International Journal of Food Microbiology 2010, 141(Suppl 1):S4-S14.
14. Chen Q., Liang D., Fromm L.D., Overbeek P.A. Inhibition of lens fiber cell morphogenesis by expression of a mutant SV40 large T antigen that binds CREB-binding protein/p300 but not pRb. The Journal of Biological Chemistry 2004, 279:17667-17673.
15. Chen T.R., Drabkowski D., Hay R.J., Macy M., Peterson W. WiDr is a derivative of another colon adenocarcinoma cell line, HT-29. Cancer Genetics and Cytogenetics 1987, 27:125-134.
16. Coller H.A., Coller B.S. Poisson statistical analysis of repetitive subcloning by the limiting dilution technique as a way of assessing hybridoma monoclonality. Methods in Enzymology 1986, 121:412-417.
17. Criss A.K., Silva M., Casanova J.E., McCormick B.A. Regulation of Salmonella-induced neutrophil transmigration by epithelial ADP-ribosylation factor 6. The Journal of Biological Chemistry 2001, 276:48431-48439.
18. Da Violante G., Zerrouk N., Richard I., Frendo J.L., Zhiri A., Li-Khuan R., et al. Short term Caco-2/TC7 cell culture: comparison between conventional 21-d and a commercially available 3-d system. Biological & Pharmaceutical Bulletin 2004, 27:1986-1992.
19. Dharmani P., Srivastava V., Kissoon-Singh V., Chadee K. Role of intestinal mucins in innate host defense mechanisms against pathogens. Journal of Innate Immunity 2009, 1:123-135.
20. Fernandez-Garcia E., Carvajal-Lerida I., Perez-Galvez A. In vitro bioaccessibility assessment as a prediction tool of nutritional efficiency. Nutrition Research 2009, 29:751-760.
21. Foligne B., Grangette C., Pot B. Probiotics in IBD: mucosal and systemic routes of administration may promote similar effects. Gut 2005, 54:727-728.
22. Fujinaga Y., Inoue K., Watarai S., Sakaguchi Y., Arimitsu H., Lee J.C., et al. Molecular characterization of binding subcomponents of Clostridium botulinum type C progenitor toxin for intestinal epithelial cells and erythrocytes. Microbiology 2004, 150:1529-1538.
23. Gao S., Jiang W., Yin T., Hu M. Highly variable contents of phenolics in St. John's Wort products affect their transport in the human intestinal Caco-2 cell model: pharmaceutical and biopharmaceutical rationale for product standardization. Journal of Agricultural and Food Chemistry 2010, 58:6650-6659.
24. Glosl S., Wagner K.H., Draxler A., Kaniak M., Lichtenecker S., Sonnleitner A., et al. Genotoxicity and mutagenicity of melanoidins isolated from a roasted glucose-glycine model in human lymphocyte cultures, intestinal Caco-2 cells and in the Salmonella typhimurium strains TA98 and TA102 applying the AMES test. Food and Chemical Toxicology 2004, 42:1487-1495.
25. Grangette C., Nutten S., Palumbo E., Morath S., Hermann C., Dewulf J., et al. Enhanced antiinflammatory capacity of a Lactobacillus plantarum mutant synthesizing modified teichoic acids. Proceedings of the National Academy of Sciences U S A 2005, 102:10321-10326.
26. Hayeshi R., Hilgendorf C., Artursson P., Augustijns P., Brodin B., Dehertogh P., et al. Comparison of drug transporter gene expression and functionality in Caco-2 cells from 10 different laboratories. European Journal of Pharmaceutical Science 2008, 35:383-396.
27. Henle G., Deinhardt F. The establishment of strains of human cells in tissue culture. The Journal of Immunology 1957, 79:54-59.
28. Hidalgo I.J. Assessing the absorption of new pharmaceuticals. Current Topics in Medicinal Chemistry 2001, 1:385-401.
29. Huang Y., Adams M.C. An in vitro model for investigating intestinal adhesion of potential dairy propionibacteria probiotic strains using cell line C2BBe1. Letters in Applied Microbiology 2003, 36:213-216.
30. Hunter C.J., Williams M., Petrosyan M., Guner Y., Mittal R., Mock D., et al. Lactobacillus bulgaricus precents intestinal epithelial cell injury caused by enterobacter sakazakii-induced nitric oxide in both in vitro and in the newborn rat model of necrotizing enterocolitis. Infection and Immunity 2009, 77:1031-1043.
31. Ingels F.M., Augustijns P.F. Biological, pharmaceutical, and analytical considerations with respect to the transport media used in the absorption screening system, Caco-2. Journal of Pharmaceutical Sciences 2003, 92:1545-1558.
32. Kim J., Hegde M., Jayaraman A. Co-culture of epithelial cells and bacteria for investigating host-pathogen interactions. Lab on a Chip 2010, 10:43-50.
33. Klein S., Cohn S.M., Alpers D.H. Alimentary tract in nutrition. Modern nutrition in health and disease (10th ed.) 2006, 1115-1142. Lippincot Williams @ Wilkins, Phildelphia, PA. M.E. Shils, M. Shike, C.A. Ross, B. Caballero, R.J. Cousins (Eds.).
34. Kojima S., Eguchi H., Ookawara T., Fujiwara N., Yasuda J., Nakagawa K., et al. Clostridium botulinum type A progenitor toxin binds to Intestine-407 cells via N-acetyllactosamine moiety. Biochemical and Biophysical Research Communications 2005, 331:571-576.
35. Lammers K.M., Helwig U., Svennen E., Rizello F., Venturi A., Caramelli E., et al. Effect of probiotic strains on interleukin 8 production by HT29/19A cells. The American Journal of Gastroenterology 2002, 97:1182-1186.
36. Larhed A.W., Artursson P., Bjork E. The influence of intestinal mucus components on the diffusion of drugs. Pharmaceutical Research 1998, 15:66-71.
37. Lebeer S., Vanderleyden J., De Keersmaecker S.C. Host interactions of probiotic bacterial surface molecules: comparison with commensals and pathogens. Nature Reviews Microbiology 2010, 8:171-184.
38. Li H., Chung S.J., Shim C.K. Characterization of the transport of uracil across Caco-2 and LLC-PK1 cell monolayers. Pharm Res 2002, 19:1495-1501.
39. Li H., Nowak-Wegrzyn A., Charlop-Powers Z., Shreffler W., Chehade M., Thomas S., et al. Transcytosis of IgE-antigen complexes by CD23a in human intestinal epithelial cells and its role in food allergy. Gastroenterology 2006, 131:47-58.
40. Lunney J.K. Advances in swine biomedical model genomics. International Journal of Biological Sciences 2007, 3:179-184.
41. Macdonald T.T., Monteleone G. Immunity, inflammation, and allergy in the gut. Science 2005, 307:1920-1925.
42. Madgula V.L., Avula B., Choi Y.W., Pullela S.V., Khan I.A., Walker L.A., et al. Transport of Schisandra chinensis extract and its biologically-active constituents across Caco-2 cell monolayers - an in-vitro model of intestinal transport. Journal of Pharmacy and Pharmacology 2008, 60:363-370.
43. Mahfoud R., Maresca M., Garmy N., Fantini J. The mycotoxin patulin alters the barrier function of the intestinal epithelium: mechanism of action of the toxin and protective effects of glutathione. Toxicology and Applied Pharmacology 2002, 181:209-218.
44. Mahler G.J., Shuler M.L., Glahn R.P. Characterization of Caco-2 and HT29-MTX cocultures in an in vitro digestion/cell culture model used to predict iron bioavailability. The Journal of Nutritional Biochemistry 2009, 20:494-502.
45. Maragkoudakis P.A., Chingwaru W., Gradisnik L., Tsakalidou E., Cencic A. Lactic acid bacteria efficiently protect human and animal intestinal epithelial and immune cells from enteric virus infection. International Journal of Food Microbiology 2010, 141(Suppl 1):S91-S97.
46. Maragkoudakis P.A., Mountzouris K.C., Psyrras D., Cremonese S., Fischer J., Cantor M.D., Tsakalidou E. Functional properties of novel protective lactic acid bacteria and application in raw chicken meat against Listeria monocytogenes and Salmonella enteritidis. International Journal of Food Microbiology 2009, 130:219-226.
47. Maragkoudakis P.A., Zoumpopoulou G., Miaris C., Kalantzopoulos G., Pot B., Tsakalidou E. Probiotic potential of Lactobacillus strains isolated from dairy products. International Dairy Journal 2006, 16:189-199.
48. Maresca M., Mahfoud R., Pfohl-Leszkowicz A., Fantini J. The mycotoxin ochratoxin A alters intestinal barrier and absorption functions but has no effect on chloride secretion. Toxicology and Applied Pharmacology 2001, 176:54-63.
49. Markowska M., Oberle R., Juzwin S., Hsu C.P., Gryszkiewicz M., Streeter A.J. Optimizing Caco-2 cell monolayers to increase throughput in drug intestinal absorption analysis. Journal of Pharmacological and Toxicological Methods 2001, 46:51-55.
50. Masago M., Takaai M., Sakata J., Horie A., Ito T., Ishida K., et al. Membrane transport mechanisms of quinidine and procainamide in renal LLC-PK1 and intestinal LS180 cells. Biological & Pharmaceutical Bulletin 2010, 33:1407-1412.
51. McNamara B.P., Koutsouris A., O'Connell C.B., Nougayrede J.P., Donnenberg M.S., Hecht G. Translocated EspF protein from enteropathogenic Escherichia coli disrupts host intestinal barrier function. Journal of Clinical Investigation 2001, 107:621-629.
52. Mine Y., Zhang J.W. Surfactants enhance the tight-junction permeability of food allergens in human intestinal epithelial Caco-2 cells. International Archives of Allergy and Immunology 2003, 130:135-142.
53. Mochizuki T., Satsu H., Totsuka M., Shimizu M. Transepithelial transport of macromolecular substances in IL-4 treated human intestinal T84 cell monolayers. Bioscience, Biotechnology, and Biochemistry 2009, 73:2422-2426.
54. Moreno F.J., Rubio L.A., Olano A., Clemente A. Uptake of 2S albumin allergens, Ber e 1 and Ses i 1, across human intestinal epithelial Caco-2 cell monolayers. Journal of Agricultural and Food Chemistry 2006, 54:8631-8639.
55. Murphy K.G., Bloom S.R. Gut hormones and the regulation of energy homeostasis. Nature 2006, 444:854-859.
56. Nanthakumar N.N., Fusunyan R.D., Sanderson I., Walker W.A. Inflammation in the developing human intestine: a possible pathophysiologic contribution to necrotizing enterocolitis. Proceedings of the National Academy of Sciences U S A 2000, 97:6043-6048.
57. Nebert D.W. Proposed role of drug-metabolizing enzymes: regulation of steady state levels of the ligands that effect growth, homeostasis, differentiation, and neuroendocrine functions. Molecular Endocrinology 1991, 5:1203-1214.
58. Nies A.T., Schwab M., Keppler D. Interplay of conjugating enzymes with OATP uptake transporters and ABCC/MRP efflux pumps in the elimination of drugs. Expert Opinion on Drug Metabolism and Toxicology 2008, 4:545-568.
59. Nishikawa A., Uotsu N., Arimitsu H., Lee J.C., Miura Y., Fujinaga Y., et al. The receptor and transporter for internalization of Clostridium botulinum type C progenitor toxin into HT-29 cells. Biochemical and Biophysical Research Communications 2004, 319:327-333.
60. Nissen L., Chingwaru W., Sgorbati B., Biavati B., Cencic A. Gut health promoting activity of new putative probiotic/protective Lactobacillus spp. strains: a functional study in the small intestinal cell model. International Journal of Food Microbiology 2009, 135:288-294.
61. Niwa K., Koyama K., Inoue S., Suzuki T., Hasegawa K., Watanabe T., et al. Role of nontoxic components of serotype D botulinum toxin complex in permeation through a Caco-2 cell monolayer, a model for intestinal epithelium. FEMS Immunology and Medical Microbiology 2007, 49:346-352.
62. Ouzilou L., Caliot E., Pelletier I., Prevost M.C., Pringault E., Colbere-Garapin F. Poliovirus transcytosis through M-like cells. Journal of General Virology 2002, 83:2177-2182.
63. Paine M.F., Khalighi M., Fisher J.M., Shen D.D., Kunze K.L., Marsh C.L., et al. Characterization of interintetinal and intraintestinal variations in human CYP3A-dependent metabolism. Journal of Pharmacology and Experimental Therapeutics 1997, 283:1552-1562.
64. Pan X., Wu T., Zhang L., Song Z., Tang H., Zhao Z. In vitro evaliation of adherence and antimicrobial properties of a candidate probiotic Clostridum butyricum CB2 for farmed fish. Journal of Applied Microbiology 2008, 105:1623-1629.
65. Pattillo R.A., Hussa R.O., Story M.T., Ruckert A.C., Shalaby M.R., Mattingly R.F. Tumor antigen and human chorionic gonadotropin in CaSki cells: a new epidermoid cervical cancer cell line. Science 1977, 196:1456-1458.
66. Peracaula R., Barrabes S., Sarrats A., Rudd P.M., de Llorens R. Altered glycosylation in tumours focused to cancer diagnosis. Disease Markers 2008, 25:207-218.
67. Pipenbaher N., Moeller P.L., Weingartl H., Dolinšek J., Jakobsen M., Cenic A. Nitric oxide (NO) production in mammalian non-tumorigenic epithelial cells of the small intestine and macrophages induced by individual strains of lactobacilli and bifidobacteria. International Dairy Journal 2009, 19:166-171.
68. Pogacar M.S., Klancnik A., Mozina S.S., Cencic A. Attachment, invasion, and translocation of Campylobacter jejuni in pig small-intestinal epithelial cells. Foodborne Pathogens and Disease 2010, 7:589-595.
69. Radtke F., Clevers H. Self-renewal and cancer of the gut: two sides of a coin. Science 2005, 307:1904-1909.
70. Rafa L., Dessein A.F., Devisme L., Buob D., Truant S., Porchet N., et al. REG4 acts as a mitogenic, motility and pro-invasive factor for colon cancer cells. International Journal of Oncology 2010, 36:689-698.
71. Regulation (EC) No 1907/2006 of the European Parliament and of the Council (2006). In: T. E. P. a. t. C. o. t. E. Union (Ed.), Official Journal of the European Union (Vol. L396, pp. 1-849).
72. Riedel C.U., Foata F., Philippe D., Adolfsson O., Eikmanss B., Blum S. Anti-inflammatory effects of bifidobacteria by inhibition of LPS-induced NF-kB activation. World Journal of Gastroenterology 2006, 12:3729-3735.
73. Riordan J.R., Ling V. Purification of P-glycoprotein from plasma membrane vesicles of Chinese hamster ovary cell mutants with reduced colchicine permeability. The Journal of Biological Chemistry 1979, 254:12701-12705.
74. Rodriguez-Lagunas M.J., Martin-Venegas R., Moreno J.J., Ferrer R. PGE2 promotes Ca2+-mediated epithelial barrier disruption through EP1 and EP4 receptors in Caco-2 cell monolayers. American Journal of Physiology - Cell Physiology 2010, 299:C324-C334.
75. Sambuy Y., De Angelis I., Ranaldi G., Scarino M.L., Stammati A., Zucco F. The Caco-2 cell line as a model of the intestinal barrier: influence of cell and culture-related factors on Caco-2 cell functional characteristics. Cell Biology and Toxicology 2005, 21:1-26.
76. Schierack P., Nordhoff M., Pollmann M., Weyrauch K.D., Amasheh S., Lodemann U., et al. Characterization of a porcine intestinal epithelial cell line for in vitro studies of microbial pathogenesis in swine. Histochemistry and Cell Biology 2006, 125:293-305.
77. Sergent T., Dupont I., Jassogne C., Ribonnet L., van der Heiden E., Scippo M.L., et al. CYP1A1 induction and CYP3A4 inhibition by the fungicide imazalil in the human intestinal Caco-2 cells-comparison with other conazole pesticides. Toxicology Letters 2009, 184:159-168.
78. Sergent T., Piront N., Meurice J., Toussaint O., Schneider Y.J. Anti-inflammatory effects of dietary phenolic compounds in an in vitro model of inflamed human intestinal epithelium. Chemico-Biological Interactions 2010, 188:659-667.
79. Sergent T., Ribonnet L., Kolosova A., Garsou S., Schaut A., De Saeger S., et al. Molecular and cellular effects of food contaminants and secondary plant components and their plausible interactions at the intestinal level. Food Chemistry and Toxicology 2008, 46:813-841.
80. Sharp P. Methods and options for estimating iron and zinc bioavailability using Caco-2 cell models: benefits and limitations. International Journal for Vitamin and Nutrition Research 2005, 75:413-421.
81. Shimizu M. Interaction between food substances and the intestinal epithelium. Bioscience, Biotechnology, and Biochemistry 2010, 74:232-241.
82. Sicherer S.H., Sampson H.A. 9. Food allergy. Journal of Allergy and Clinical Immunology 2006, 117:S470-S475.
83. Simon-Assmann P., Turck N., Sidhoum-Jenny M., Gradwohl G., Kedinger M. In vitro models of intestinal epithelial cell differentiation. Cell Biology and Toxicology 2007, 23:241-256.
84. Tafazoli F., Holmstrom A., Forsberg A., Magnusson K.E. Apically exposed, tight junction-associated beta1-integrins allow binding and YopE-mediated perturbation of epithelial barriers by wild-type Yersinia bacteria. Infection and Immunity 2000, 68:5335-5343.
85. Tang F., Horie K., Borchardt R.T. Are MDCK cells transfected with the human MRP2 gene a good model of the human intestinal mucosa?. Pharmaceutical Research 2002, 19:773-779.
86. Tavelin S., Taipalensuu J., Soderberg L., Morrison R., Chong S., Artursson P. Prediction of the oral absorption of low-permeability drugs using small intestine-like 2/4/A1 cell monolayers. Pharmaceutical Research 2003, 20:397-405.
87. Tian X.J., Yang X.W., Yang X., Wang K. Studies of intestinal permeability of 36 flavonoids using Caco-2 cell monolayer model. International Journal of Pharmacology 2009, 367:58-64.
88. Tirelli V., Catone T., Turco L., Di Consiglio E., Testai E., De Angelis I. Effects of the pesticide clorpyrifos on an in vitro model of intestinal barrier. Toxicology in Vitro 2007, 21:308-313.
89. Tremblay E., Auclair J., Delvin E., Levy E., Menard D., Pshezhetsky A.V., et al. Gene expression profiles of normal proliferating and differentiating human intestinal epithelial cells: a comparison with the Caco-2 cell model. Journal of Cellular Biochemistry 2006, 99:1175-1186.
90. Umar S. Intestinal stem cells. Current Gastroenterology Reports 2010, 12:340-348.
91. van Hoffen E., Korthagen N.M., de Kivit S., Shouten B., Bardoel B., Duivelshof A., Knol J., et al. Exposure of intestinal epithelial cells to uv-killed Lactobacillus GG but not Bifidobacterium Breve enhances the effector immune response in vitro. International Archives of Allergy and Immunology 2010, 152:159-168.
92. Vidau C., Brunet J.L., Badiou A., Belzunces L.P. Phenylpyrazole insecticides induce cytotoxicity by altering mechanisms involved in cellular energy supply in the human epithelial cell model Caco-2. Toxicology in Vitro 2009, 23:589-597.
93. Wacher V.J., Silverman J.A., Zhang Y., Benet L.Z. Role of P-glycoprotein and cytochrome P450 3A in limiting oral absorption of peptides and peptidomimetics. Journal of Pharmaceutical Sciences 1998, 87:1322-1330.
94. Wagner R.D., Krul E.S., Moberly J.B., Alpers D.H., Schonfeld G. Apolipoprotein expression and cellular differentiation in Caco-2 intestinal cells. American Journal of Physiology 1992, 263:E374-E382.
95. Wasserman S.I., Barrett K.E., Huott P.A., Beuerlein G., Kagnoff M.F., Dharmsathaphorn K. Immune-related intestinal Cl- secretion. I. Effect of histamine on the T84 cell line. American Journal of Physiology 1988, 254:C53-C62.
96. Westendorf A.M., Fleissner D., Hansen W., Buer J. T cells, dendritic cells and epithelial cells in intestinal homeostasis. International Journal of Medical Microbiology 2010, 300:11-18.
97. Yang J., Tucker G.T., Rostami-Hodjegan A. Cytochrome P450 3A expression and activity in the human small intestine. Clinical Pharmacology & Therapeutics 2004, 76:391.
98. Yang P.C., He S.H., Zheng P.Y. Investigation into the signal transduction pathway via which heat stress impairs intestinal epithelial barrier function. Journal of Gastroenterology and Hepatology 2007, 22:1823-1831.
99. Zoumpopoulou G., Tsakalidou E., Dewulf J., Pot B., Grangette C. Differential Crosstalk between epithelial cells, dendritic cells and bacteria in a co-culture model. International Journal of Food Microbioloby 2009, 131:40-51.